{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:48:55Z","timestamp":1779122935705,"version":"3.51.4"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Extracorporeal photopheresis (ECP) is a viable treatment that slows the progression of chronic lung allograft dysfunction. Despite its immunoregulatory potential, data on extracorporeal photopheresis as an induction therapy remain rather limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a pilot randomized controlled study on ECP as induction therapy in cystic fibrosis patients undergoing primary lung transplantation. Primary endpoints included safety, assessed based on the incidence of adverse events, treatment-related toxicity, and procedure-related complication rates; and feasibility, evaluated through the completion rate of scheduled ECP sessions, patient tolerability, and treatment discontinuation rates. Secondary endpoint consisted of an exploratory assessment of efficacy, using a composite measure that included three key components: freedom from biopsy-proven acute rejection within the first 12 months, absence of chronic lung allograft dysfunction at 36 months, and optimal graft function, defined as a predicted forced expiratory volume in the first second \u2265 90% at 36 months. Finally, exploratory endpoints included cell phenotypic and functional analyses, secreted immune protein profiling, and gene expression analysis for mechanistic insights. Patients were randomly assigned to receive either standard immunosuppressive therapy alone or standard therapy plus six sessions of extracorporeal photopheresis, with a follow-up period of 36 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 36 cystic fibrosis patients who underwent lung transplantation between 2018 and 2021 and met the eligibility criteria, 21 were randomized (9 to the study group and 12 to the control group). No patients in the treatment group experienced adverse events. The enrollment rate was 61%, and the treatment discontinuation rate was 22%. The clinical composite endpoint was achieved by 28.6% of patients in the treatment group and 16.7% in the control group. Exploratory endpoint analyses revealed significant decreases in pro-inflammatory cytokines, degranulating CD8<jats:sup>+<\/jats:sup> T lymphocytes, and NK cells in the treatment group. Moreover, significant increases in Treg lymphocytes, IL-10-producing NK cells, and anti-inflammatory cytokines appeared to be associated with improved pulmonary function in the treatment group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Induction therapy with extracorporeal photopheresis is safe and feasible in lung transplantation for cystic fibrosis. Some clinical benefits appear to persist for the first 36 months of follow-up. Interestingly, a correlation between immunological modulation induced by extracorporeal photopheresis and pulmonary function was observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Trial Registration<\/jats:title><jats:p><jats:uri>https:\/\/clinicaltrials.gov\/study\/NCT03500575?cond=NCT03500575&amp;amp;rank=1<\/jats:uri>, identifier NCT03500575.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1583460","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:11:16Z","timestamp":1747368676000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Extracorporeal photopheresis as induction therapy in lung transplantation for cystic fibrosis: a pilot randomized trial"],"prefix":"10.3389","volume":"16","author":[{"given":"Ilaria","family":"Righi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Fenizia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"Trabattoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Nosotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Grisorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Vanetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"di Tella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mocellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma","family":"Fantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Prati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia Corinna","family":"Morlacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo Paolo","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.21037\/jtd-22-1414","article-title":"Twenty-year survival following lung transplantation","volume":"15","author":"Miggins","year":"2023","journal-title":"J Thorac Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.12.009","article-title":"Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection","volume":"39","author":"Gunasekaran","year":"2020","journal-title":"J Heart Lung Transplantation"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2012.08.004","article-title":"The registry of the international society for heart and lung transplantation: 29th adult lung and heart-lung transplant report\u20142012","volume":"31","author":"Christie","year":"2012","journal-title":"J Heart Lung Transplantation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.healun.2012.03.008","article-title":"Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation","volume":"31","author":"Treede","year":"2012","journal-title":"J Heart Lung Transplantation"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.04.022","article-title":"Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1","volume":"28","author":"Burton","year":"2009","journal-title":"J Heart Lung Transplantation"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.07.021","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report \u2014 2021; Focus on recipient characteristics","volume":"40","author":"Chambers","year":"2021","journal-title":"J Heart Lung Transplantation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2024.03.012","article-title":"The use of extracorporeal photopheresis in solid organ transplantation\u2014current status and future directions","volume":"24","author":"Barten","year":"2024","journal-title":"Am J Transplantation"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002168","article-title":"Extracorporeal photopheresis for bronchiolitis obliterans syndrome after lung transplantation","volume":"102","author":"Hachem","year":"2018","journal-title":"Transplantation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-001995","article-title":"Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK)","volume":"11","author":"Fisher","year":"2024","journal-title":"BMJ Open Resp Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e32832ce943","article-title":"Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells","volume":"14","author":"Xia","year":"2009","journal-title":"Curr Opin Organ Transplantation"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13539","article-title":"CD11c+ dendritic cells mediate antigen-specific suppression in extracorporeal photopheresis","volume":"203","author":"Hackstein","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.01.780","article-title":"Extracorporeal photoimmune therapy (ECP) with UVADEX in conjunction with standard therapy compared to standard therapy alone for the prevention of rejection in lung transplantation patients","volume":"33","author":"Jaksch","year":"2014","journal-title":"J Heart Lung Transplantation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2400733","DOI":"10.1183\/13993003.00733-2024","article-title":"Extracorporeal photopheresis for the prevention of rejection after lung transplantation: a prospective randomised controlled trial","volume":"65","author":"Benazzo","year":"2025","journal-title":"Eur Respir J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplantation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.healun.2016.01.1223","article-title":"Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation","volume":"35","author":"Levine","year":"2016","journal-title":"J Heart Lung Transplantation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1053-2498(02)00398-4","article-title":"Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria","volume":"21","author":"Estenne","year":"2002","journal-title":"J Heart Lung Transplantation"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31822bf790","article-title":"Survival determinants in lung transplant patients with chronic allograft dysfunction","volume":"92","author":"Verleden","year":"2011","journal-title":"Transplantation"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12663","article-title":"A randomized, double-blind, placebo-controlled, multicenter study of rabbit ATG in the prophylaxis of acute rejection in lung transplantation","volume":"14","author":"Snell","year":"2014","journal-title":"Am J Transplantation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/BF02291575","article-title":"An index of factorial simplicity","volume":"39","author":"Kaiser","year":"1974","journal-title":"Psychometrika"},{"key":"B20","unstructured":"The jamovi project\n          \n          \n          2022"},{"key":"B21","unstructured":"A Language and environment for statistical computing"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/ph17101279","article-title":"Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease","volume":"17","author":"Gavriilaki","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.12897","article-title":"Diaphragm and lung transplantation","volume":"37","author":"Palleschi","year":"2024","journal-title":"Transpl Int"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2014.938353","article-title":"Serum levels of IL-10, IL-17F and IL-33 in patients with asthma: a case\u2013control study","volume":"51","author":"Raeiszadeh Jahromi","year":"2014","journal-title":"J Asthma"},{"key":"B25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12931-017-0662-2","article-title":"The value of blood cytokines and chemokines in assessing COPD","volume":"18","author":"Bradford","year":"2017","journal-title":"Respir Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1583460\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:11:18Z","timestamp":1747368678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1583460\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":25,"alternative-id":["10.3389\/fimmu.2025.1583460"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1583460","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"article-number":"1583460"}}